Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1979 1
1981 3
1985 1
1989 3
1990 1
1993 1
1997 1
2001 3
2002 4
2003 3
2004 4
2005 11
2006 6
2007 6
2008 5
2009 14
2010 6
2011 8
2012 8
2013 9
2014 4
2015 4
2016 7
2017 2
2018 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Results by year
Filters applied: . Clear all
Page 1
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: senzer n. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
siRNA vs. shRNA: similarities and differences.
Rao DD, Vorhies JS, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: senzer n. Adv Drug Deliv Rev. 2009 Jul 25;61(9):746-59. doi: 10.1016/j.addr.2009.04.004. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19389436 Review.
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.
Metzinger MN, Verghese C, Hamouda DM, Lenhard A, Choucair K, Senzer N, Brunicardi FC, Dworkin L, Nemunaitis J. Metzinger MN, et al. Among authors: senzer n. Oncology. 2019;97(2):59-74. doi: 10.1159/000500488. Epub 2019 Jul 1. Oncology. 2019. PMID: 31261152 Review.
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.
Jamieson SM, Tsai P, Kondratyev MK, Budhani P, Liu A, Senzer NN, Chiorean EG, Jalal SI, Nemunaitis JJ, Kee D, Shome A, Wong WW, Li D, Poonawala-Lohani N, Kakadia PM, Knowlton NS, Lynch CR, Hong CR, Lee TW, Grénman RA, Caporiccio L, McKee TD, Zaidi M, Butt S, Macann AM, McIvor NP, Chaplin JM, Hicks KO, Bohlander SK, Wouters BG, Hart CP, Print CG, Wilson WR, Curran MA, Hunter FW. Jamieson SM, et al. Among authors: senzer nn. JCI Insight. 2018 Aug 23;3(16):e122204. doi: 10.1172/jci.insight.122204. eCollection 2018 Aug 23. JCI Insight. 2018. PMID: 30135316 Free PMC article. Clinical Trial.
Tumor vaccines and cellular immunotherapies.
Nemunaitis J, Senzer N, Plato L. Nemunaitis J, et al. Among authors: senzer n. Ann Transl Med. 2016 Oct;4(Suppl 1):S24. doi: 10.21037/atm.2016.10.54. Ann Transl Med. 2016. PMID: 27867992 Free PMC article. No abstract available.
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
Oh J, Barve M, Matthews CM, Koon EC, Heffernan TP, Fine B, Grosen E, Bergman MK, Fleming EL, DeMars LR, West L, Spitz DL, Goodman H, Hancock KC, Wallraven G, Kumar P, Bognar E, Manning L, Pappen BO, Adams N, Senzer N, Nemunaitis J. Oh J, et al. Among authors: senzer n. Gynecol Oncol. 2016 Dec;143(3):504-510. doi: 10.1016/j.ygyno.2016.09.018. Epub 2016 Sep 24. Gynecol Oncol. 2016. PMID: 27678295 Clinical Trial.
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy.
Alqahtani A, Choucair K, Ashraf M, Hammouda DM, Alloghbi A, Khan T, Senzer N, Nemunaitis J. Alqahtani A, et al. Among authors: senzer n. Future Sci OA. 2019 Jan 29;5(3):FSO372. doi: 10.4155/fsoa-2018-0115. eCollection 2019 Mar. Future Sci OA. 2019. PMID: 30906568 Free PMC article. Review.
Summary of bi-shRNA/GM-CSF augmented autologous tumor cell immunotherapy (FANG™) in advanced cancer of the liver.
Nemunaitis J, Barve M, Orr D, Kuhn J, Magee M, Lamont J, Bedell C, Wallraven G, Pappen BO, Roth A, Horvath S, Nemunaitis D, Kumar P, Maples PB, Senzer N. Nemunaitis J, et al. Among authors: senzer n. Oncology. 2014;87(1):21-9. doi: 10.1159/000360993. Epub 2014 Jun 25. Oncology. 2014. PMID: 24968881 Clinical Trial.
RNA interference and personalized cancer therapy.
Rao DD, Wang Z, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: senzer n. Discov Med. 2013 Feb;15(81):101-10. Discov Med. 2013. PMID: 23449112 Free article. Review.
Chemo-inducible gene therapy.
Mezhir JJ, Schmidt H, Yamini B, Senzer NN, Posner MC, Kufe DW, Weichselbaum RR. Mezhir JJ, et al. Among authors: senzer nn. Anticancer Drugs. 2005 Nov;16(10):1053-8. doi: 10.1097/00001813-200511000-00003. Anticancer Drugs. 2005. PMID: 16222146 Review.
114 results
Jump to page
Feedback